Effect of Dapagliflozin in DAPA-HF According to Background Glucose-Lowering Therapy
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To determine whether the benefits of dapagliflozin in patients with heart failure and reduced ejection fraction (HFrEF) and type 2 diabetes in the Dapagliflozin And Prevention of Adverse-Outcomes in Heart Failure trial (DAPA-HF) varied by background glucose-lowering therapy (GLT). RESEARCH DESIGN AND METHODS: We examined the effect of study treatment by the use or not of GLT and by GLT classes and combinations. The primary outcome was a composite of worsening heart failure (hospitalization or urgent visit requiring intravenous therapy) or cardiovascular death. RESULTS: In the 2,139 type 2 diabetes patients, the effect of dapagliflozin on the primary outcome was consistent by GLT use or no use (hazard ratio 0.72 [95% CI 0.58–0.88] vs. 0.86 [0.60–1.23]; interaction P = 0.39) and across GLT classes. CONCLUSIONS: In DAPA-HF, dapagliflozin improved outcomes irrespective of use or no use of GLT or by GLT type used in patients with type 2 diabetes and HFrEF.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This effect was consistent across patients with and without diabetes at baseline.495”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [495]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab670 · Cited by 19,442
Self-citation2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw128 · Cited by 11,429
Self-citationDapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
McMurray, J. J. V., Solomon, S. D., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Anand, I. S., Bělohlávek, J., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1911303 · Cited by 7,140
Self-citationCanagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
Perkovic, V., Jardine, M. J., Neal, B., Bompoint, S., Heerspink, H. J. L., Charytan, D. M., Edwards, R., Agarwal, R., Bakris, G., Bull, S., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1811744 · Cited by 6,189
Self-citationCosentino, F., Grant, P. J., Aboyans, V., Bailey, C. J., Ceriello, A., Delgado, V., Federici, M., Filippatos, G., Grobbee, D. E., Hansen, T. B., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz486 · Cited by 4,763
Davies, M. J., D’Alessio, D. A., Fradkin, J., Kernan, W. N., Mathieu, C., Mingrone, G., Rossing, P., Tsapas, A., Wexler, D. J., & Buse, J. B. (2018) · Diabetes Care · doi:10.2337/dci18-0033 · Cited by 3,518
Zelniker, T. A., Wiviott, S. D., Raz, I., Im, K., Goodrich, E. L., Bonaca, M. P., Mosenzon, O., Kato, E. T., Cahn, A., Furtado, R. H. M., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32590-x · Cited by 2,845
Self-citationDavies, M. J., D’Alessio, D. A., Fradkin, J., Kernan, W. N., Mathieu, C., Mingrone, G., Rossing, P., Tsapas, A., Wexler, D. J., & Buse, J. B. (2018) · Diabetologia · doi:10.1007/s00125-018-4729-5 · Cited by 1,455
Garber, A. J., Handelsman, Y., Grunberger, G., Einhorn, D., Abrahamson, M. J., Barzilay, J. I., Blonde, L., Bush, M. A., DeFronzo, R. A., Garber, J. R., et al. (2020) · Endocrine Practice · doi:10.4158/cs-2019-0472 · Cited by 598
Petrie, M. C., Verma, S., Docherty, K. F., Inzucchi, S. E., Anand, I., Belohlávek, J., Böhm, M., Chiang, C.-E., Chopra, V. K., de Boer, R. A., et al. (2020) · JAMA · doi:10.1001/jama.2020.1906 · Cited by 531
Self-citation
Cited by
2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes.
Marx, N., Federici, M., Schütt, K., Müller-Wieland, D., Ajjan, R. A., Antunes, M. J., Christodorescu, R. M., Crawford, C., Di Angelantonio, E., Eliasson, B., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad192 · Cited by 1,642
Self-citationNeuen, B. L., Arnott, C., Perkovic, V., Figtree, G., de Zeeuw, D., Fulcher, G., Jun, M., Jardine, M. J., Zoungas, S., Pollock, C., et al. (2021) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14226 · Cited by 78
Herrington, W. G., Savarese, G., Haynes, R., Marx, N., Mellbin, L., Lund, L. H., Dendale, P., Seferovic, P., Rosano, G., Staplin, N., et al. (2021) · European Journal of Heart Failure · doi:10.1002/ejhf.2286 · Cited by 63
Inzucchi, S. E., Claggett, B. L., Vaduganathan, M., Desai, A. S., Jhund, P. S., de Boer, R. A., Hernandez, A. F., Kosiborod, M., Lam, C. S. P., Martínez, F. A., et al. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(22)00308-4 · Cited by 57
Self-citationSavarese, G., Butler, J., Lund, L. H., Bhatt, D. L., & Anker, S. D. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab271 · Cited by 48
Greene, S. J., Butler, J., & Kosiborod, M. (2024) · The American Journal of Medicine · doi:10.1016/j.amjmed.2023.04.019 · Cited by 29
Self-citationDihoum, A., Rena, G., Pearson, E. R., Lang, C. C., & Mordi, I. R. (2023) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2023.2196010 · Cited by 33
“Data from recent SGLT2i trials have shown that the cardiovascular benefits of SGLT2i are maintained regardless of background glucose lowering therapy [62].”
BackgroundSelf-citationDapagliflozin: A Review in Symptomatic Heart Failure with Reduced Ejection Fraction
Blair, H. A. (2021) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-021-00503-8 · Cited by 28
“Additional post hoc analyses demonstrated that the benefit of dapagliflozin on the primary composite endpoint was independent of race (black vs white) [29], mortality risk score [30], duration of HF [31], prior HHF [18], anemia status [32], presence of chronic obstructive pulmonary disease [33], Kansas City Cardiomyop…”
BackgroundMetra, M., Tomasoni, D., Adamo, M., Amir, O., Anker, S. D., Bayés‐Genís, A., Böehm, M., Butler, J., Chioncel, O. D., Filippatos, G. S., et al. (2025) · ESC Heart Failure · doi:10.1002/ehf2.15408 · Cited by 28
Self-citationLassen, M. C. H., Ostrominski, J. W., Inzucchi, S. E., Claggett, B. L., Kulac, I. J., Jhund, P. S., de Boer, R. A., Hernandez, A. F., Kosiborod, M., Lam, C. S. P., et al. (2024) · European Journal of Heart Failure · doi:10.1002/ejhf.3269 · Cited by 14
Self-citationTanaka, A., Toyoda, S., Imai, T., Shiina, K., Tomiyama, H., Matsuzawa, Y., Okumura, T., Kanzaki, Y., Onishi, K., Kiyosue, A., et al. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01369-5 · Cited by 13
Self-citationEscobar, C., Pascual-Figal, D. A., Manzano, L., Núñez, J. E., & Camafort, M. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12216798 · Cited by 14
“Finally, the benefits of dapagliflozin were independent of background glucose-lowering therapy (P for interaction 0.39 for the primary endpoint) or the type used, among those patients with type 2 diabetes from the DAPA-HF trial [68].”
MethodInfluentialSingh, A. K., & Singh, R. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108536 · Cited by 7
Dapagliflozin — a key pawn on the new guidelines chessboard
Kubica, J. (2021) · Medical Research Journal · doi:10.5603/mrj.a2021.0056 · Cited by 6
Positionspapier Herzinsuffizienz und Diabetes
Schütt, K. S., Aberle, J., Bauersachs, J. K., Birkenfeld, A. L., Frantz, S., Ganz, M., Jacob, S., Kellerer, M., Leschke, M., Liebetrau, C., et al. (2022) · Diabetologie und Stoffwechsel · doi:10.1055/a-1867-3026 · Cited by 6
Self-citationAn Exploration of the Experience of Dapagliflozin in Clinical Practice
Anuba, P. A., Balasubramanian, S., Arun, G. R., Kennady, S. R. S., Ganamurali, N., Dhanasekaran, D., & Sabarathinam, S. (2022) · Future Science OA · doi:10.2144/fsoa-2022-0038 · Cited by 7
Singh, A. K., Singh, R., & Singh, R. (2023) · Endocrine Practice · doi:10.1016/j.eprac.2023.04.001 · Cited by 6
Job Satisfaction among Primary Health Care Workers in Buraidah, Qassim, Saudi Arabia
Aljumail, E., & Rabbani, U. (2021) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2021.94173 · Cited by 6
Alasmari, I. H., Saleh, M. M. A., Alahmari, M. A., Asiri, S. M., & Asiri, A. Y. (2021) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2021.94184 · Cited by 4
Alomary, S. A., Alorainy, B. A., Albargan, N. S., Alotaibi, F. Z., & Alkholaiwi, F. (2021) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2021.94191 · Cited by 4
Altaf, M., Altaf, L. Z., Farahat, F. M., & Althaqafi, A. (2021) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2021.94170 · Cited by 3
Positionspapier Herzinsuffizienz und Diabetes
Schütt, K. S., Aberle, J., Bauersachs, J. K., Birkenfeld, A. L., Frantz, S., Ganz, M., Jacob, S., Kellerer, M., Leschke, M., Liebetrau, C., et al. (2022) · Die Kardiologie · doi:10.1007/s12181-022-00562-4 · Cited by 3
Self-citationSchool Teachers’ Knowledge and Attitude toward School Students with Epilepsy
Alsugair, R. S., Alyabis, M. A., Algadi, M. A., Attieh, A. I., Juha, L. A., Alawa, R. G., Alghannam, S. G., Alsaadoon, N. Z., El-Sayed, N., & Alfadeel, M. A. (2021) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2021.94183 · Cited by 3
El-Gamal, F., Alsubhi, N., Badr, S., Althaqafi, N., Al-Qadasi, F., & Hammed, M. (2021) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2021.94179 · Cited by 2
Rethinking the Impact and Management of Diabetes in Heart Failure Patients
Schütt, K. S. (2023) · Current Heart Failure Reports · doi:10.1007/s11897-023-00633-x · Cited by 5
“These positive effects were observed in patients with and without DM, across the entire range of HbA1c levels, and were independent of concurrent antidiabetic treatment [41, 42].”
BackgroundUse of Sodium-Glucose Cotransporter Inhibitors in Type 1 Diabetes: The Promise and the Perils
Peter, P. R., & Inzucchi, S. E. (2024) · Endocrine Practice · doi:10.1016/j.eprac.2024.03.022 · Cited by 3
Self-citationSingh, A. K., & Singh, R. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108648 · Cited by 2
Dapagliflozina en la prevención y tratamiento de la insuficiencia cardiaca
Egocheaga, I., Escobar, C., Pallarés‐Carratalá, V., & Obaya, J. C. (2021) · Medicina de Familia SEMERGEN · doi:10.1016/j.semerg.2021.10.001 · Cited by 1
Environmental Triggers in Migraine patients in Riyadh: A Cross-Sectional Study
Harbi, A. A., Alzahrani, N. H., Alsuhibany, H. A., Aldosari, M. A. A., Alsalman, R. S., & Alkhalifah, A. (2021) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2021.94172 · Cited by 1
Effectiveness of Community Mental Health Service in Oman: A Pilot Study
Al-Jadidi, S., Aboalatta, A. S., Al-Rahbi, I., Al-Harrasi, M., AlRauzaiqi, H., Sabeih, M. A., AlGammari, T., & Al-Shammakhi, A. (2021) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2021.94180 · Cited by 3
Kaur, A., Singh, P., Singh, G., Mohan, G., Chopra, G., & Singh, R. (2021) · International Journal of Advances in Medicine · doi:10.18203/2349-3933.ijam20212875 · Cited by 1
“Docherty et al described that in diabetic patients with HF, the reductions in the risk of worsening HF and cardiovascular death with dapagliflozin is found and it is recommended as first-line monotherapy.(5)”
BackgroundIncreased Psychological Disorders among Pediatric Population during Covid
AlQaatri, H. A. J. H. (2021) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2021.94174 · Cited by 1
Dapagliflozin verbessert Herzprognose unabhängig von übrigen Antidiabetika
(2021) · Diabetologie und Stoffwechsel · doi:10.1055/a-1327-9735
Ahmed, S. F., Alghamdi, G. A., Albalawi, A. A., AlQahtani, M., Ghonim, I. M., Elhady, H. M., Abdelhamid, S. A., & Eldesouky, A. A. (2021) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2021.94189
Ballaji, W. K., & Hadadi, H. M. (2021) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2021.94186
Barriers to Compliance of Hypertensive Patients in Abha City, Saudi Arabia
Almonawar, A. A., Alasmary, A. S., Mogbel, M. M., & Almojamad, H. M. (2021) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2021.94177 · Cited by 1
Role of SGLT2 Inhibitors and GLP-1 Analogs in Cardiovascular Risk Reduction in Type 2 Diabetes
Rashed, M. H., Dauyoumor, T. D., Corney, S. M., Konono, K., Joubert, N., Mohamed, M., Sukhoo-Pertab, M., Makhomisane, M., Njeri, I., Mwita, J. C., et al. (2021) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2021.94188
Diagnostic approach to eosinophilia in children
Shasho, R. (2021) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2021.94190
Knowledge, Attitude and Practice of Non-Psychiatric Physicians about Addiction
Al-Ahmari, S. M., Almusa, A. A., Alshomrani, A. A., Ahmary, W. S. H. A., Assiry, Z. S. A., Alqahtany, S. M. S., Asiri, A. Y., Alqahtani, T. S., Alassiri, N. S., & Mostafa, O. A. (2021) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2021.94185
Schütt, K. S. (2022) · Diabetes aktuell · doi:10.1055/a-1881-3116
Herzinsuffizienz bei Patienten mit Diabetes mellitus
Schütt, K. S., & Polzin, A. (2024) · Aktuelle Kardiologie · doi:10.1055/a-2318-3573
Kumar, K. P. N. S., Variam, M. T., Bala Vignesh, S., Nath, K., Goyal, K. K., Beswal, G., Arun, P., Narayan, K., Kumar, S. P. S., Ravindranath, V., et al. (2025) · Cardiovascular Endocrinology & Metabolism · doi:10.1097/xce.0000000000000334
Tanaka, A., Toyoda, S., Imai, T., Shiina, K., Tomiyama, H., Matsuzawa, Y., Okumura, T., Kanzaki, Y., Onishi, K., Kiyosue, A., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16570283
Self-citationMarx-Schütt, K. (2026) · Elsevier eBooks · doi:10.1016/b978-0-323-87862-3.00016-1
Metadata
- Authors
- Docherty, K. F., Jhund, P. S., Bengtsson, O., DeMets, D. L., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Langkilde, A. M., Martinez, F. A., Sabatine, M. S., Sjöstrand, M., Solomon, S. D., McMurray, J. J. V., DAPA-HF Investigators and Committees, Diez, M., Sassone, S., Aizenberg, D., Talavera, M., Mercau, G., Martinez, D., Albisu, J., Hershson, A., GarcíaDurán, R., Hominal, M., Cluigt, N., ColomboBerra, F., Perna, E., AhuadGuerrero, R., GarcíaBrasca, D., Zaidman, C., Majul, C., Taborda, J., Luquez, H., Sala, J., SosaLiprandi, A., Cursack, G., Montaña, O., Fernandez, A., Najenson, M., Nani, S., Caruso, G., Fairman, E., PereiroGonzalez, S., Maia, L., Pereira, A., Rossi, P., Precoma, D., Neuenschwander, F., Reis, G., Guimaraes, F., Saraiva, J., Arantes, F., Hernandes, M., Borges, J., Paolino, B., Vasconcellos, E., Manenti, E., Pimentel, P., Leaes, P., Rassi, S., Dalcoquio, T., Katova, T., Avramov, D., Spasova, N., Raev, D., Chompalova, B., Milanova, M., Tokmakova, M., Runev, N., Mihov, A., Gogov, A., Dincheva, A., Iliev, N., Kolomanov, B., Ivanova, Y., Ilieva, K., Karageorgiev, D., Petrov, I., Botushanov, N., Vladeva, S., Constance, C., Vizel, S., Pandey, A., Phaneuf, D.-C., Mehta, S., Rupka, D., Pesant, Y., Poirier, P., Chehayeb, R., Babapulle, M., O’Meara, E., Howlett, J., Yao, L., McKelvie, R., Verma, S., Hartleib, M., Vijayaraghavan, R., Vyselaar, J., Azzari, F., Cha, J., Nasser-Sharif, F., Maung, T., Mansour, S., Khaykin, Y., Lee, R., Fong, P., Ge, J., Jiang, H., Li, X., Fu, L., Li, Y., Wang, D., Zhao, Q., Dong, Y., Zhou, Y., Lin, X., Dong, J., Zhang, X., Zheng, Z., Huang, W., Gu, Y., Liu, J., Guo, X., Wu, L., Tang, Q., Peng, D., Dong, W., Liang, Y., Wang, D., Wu, C., Li, Z., Lin, X., Zhang, X., Wang, Z., Han, B., Belohlavek, J., Slaby, J., Spinar, J., Hajek, P., Busak, L., Carda, J., Spinarova, L., Malek, I., Skopek, J., Kuchar, R., Krcova, E., Mayer, O., Kucera, D., Schou, M., Køber, L., Egstrup, K., Hove, J., Gislason, G., Videbæk, L., Böhm, M., Nischik, R., Toursarkissian, N., Appel, K.-F., Schmidt, E., Weigmann, I., Kellerer, M., Al-Zoebi, A., Stephan, U., Wilke, A., Genth-Zotz, S., Simonis, G., Tschöpe, D., Costard-Jäckle, A., Petrie, M., Gardner, R., Clark, A., Japp, A., Jhund, P., Lang, C., Leslie, S., Murphy, C., Petrie, C., Walsh, J., Merkely, B., Andrássy, P., Noori, E., Járai, Z., Poór, F., Király, C., Czigány, A., Nagy, L., Motyovszki, Á., Masszi, G., Mehta, V., Chopra, V, Naik, A., Gadkari, M., Sawant, R., Mahapekar, M., Karna, S., Deshpande, M., Bhargava, V., Kothiwale, V., Menon, J., Sinha, D., Sinha, S., Kokane, H., Udgire, P., Sandhu, M., Suzuki, M., Nishino, M., Kiyosue, A., Sumii, K., Suzuki, S., Noguchi, Y., Tanaka, S., Takase, H., Mohri, M., Higashiue, S., Fujimoto, N., Iseki, H., Kuramochi, T., Shibasaki, T., Tsutsui, H., Takagi, Y., Sakuragi, S., Takeyasu, N., Kitakaze, M., Izumi, C., Oga, T., Kimura, A., Kakuta, T., Hashimoto, T., Sugino, H., Saito, K., Hiroi, S., kamiya, H., Fukui, K., Matsuoka, S., Moritani, K., Tomobuchi, Y., Hata, Y., Kawamura, R., Hattori, E., Fujimoto, K., Takahashi, N., Takahashi, W., Kadokami, T., Ueno, H., Uchikawa, S., Shinozaki, T., Onishi, Y., Komiyama, N., Inoue, S., Momiyama, Y., Ueda, Y., Komura, Y., Hayashida, R., Masuda, S., Higuchi, M., Hayashi, Y., Seki, K., Fujii, K., Harada, K., Wada, A., Kasai, T., Kuwahara, K., Oishi, S., Uchida, I., Okumura, Y., Hisamatsu, Y., Nunohiro, T., Tsukahara, K., Hirohata, A., Asakura, M., deBoer, R., Bellersen, L., Swart, H., Groenemeijer, B., ZoetNugteren, S., deNooijer, C., Nierop, P., RoblesdeMedina, R., vanEck, J., vanHessen, M., Drożdż, J., Miękus, P., Ściborski, R., Mikłaszewicz, B., Sudnik, W., Mariankowski, R., Witek, R., Drelich, G., Mirek-Bryniarska, E., Szynal, S., Pawłowicz, L., Lampart, J., Korzeniak, R., Prokopczuk, J., Boldueva, S., Didenko, Y., Dzhaiani, N., Ermoshkina, L., Kostenko, V., Vishneva, E., Koziolova, N., Tereschenko, S., Pevzner, D., Krylova, L., Chernyavsky, A., Kazakov, A., Aksentiev, S., Nilk, R., Paltsman, Z., Galyavich, A., Maltcev, A., Kopylov, P., Ezhov, A., Shilko, J., Antalik, L., Bugan, V., Fulop, P., Jamriskova, L., Kollarova, D., Macek, V., Slovenska, M., Tomasova, L., Vinanska, D., Smik, R., Selecky, J., Majercak, I., Olexa, P., Ljungman, C., Hedman, A., Lindholm, C.-J., Lindmark, K., Mooe, T., Chiang, C., Lin, L.-Y., Liu, M.-E., Chang, K.-C., Hsia, C.-H., Shih, J.-Y., Liu, P.-Y., Lin, T.-H., Chang, H.-Y., Huang, J.-L., Hsieh, I.-C., Wu, C.-C., Tseng, W.-K., Arif, A., Avino, D., Banerjee, S., Kanwar, M., Berk, M., Brown, C., Ince, C., Lewis, T., Nikfarjam, A., Patel, J., Ramanathan, K., Schabauer, A., Greene, T., Shah, K., Sotolongo, R., Viera, A., Akinboboye, O., Arouni, A., Bertolet, B., Chandra, L., Cimato, T., DeLeon, S., Bennett, M., Franchi, F., Hamroff, G., Hotchkiss, D., Jardula, M., Javier, J., Kazemi, N., Kostis, J., Lash, J., Levinson, L., Lieber, I., Lo, E., Mahal, S., Manshadi, R., Mody, F., Paraschos, A., Pursley, M., Hickey, G., Londono, J., Singal, D., Srivastava, S., Teel, J., Castriz, J., Kantaros, L., Venugopal, C., Staniloae, C., Gupta, D., Syed, F., Zacharias, M., Jaffrani, N., Wakefield, P., Nassif, M., Haddad, T., Iskander, S., Lewis, G., Al-Joundi, B., French, W., Ogunniyi, M., Emani, S., Weiss, S., Cheng, R., Florea, V., Joseph, S., Gupta, D., Lederman, S., Izzo, J., Bernstein, M., Fruehling, E., Foley, B., Younis, L., Song, D., Pham, V., Nguyen, H., Do, H., Truong, B., Nguyen, H., Nguyen, T., Nguyen, H., & Ho, D.
- Affiliations
- University of Glasgow (GB)
- BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, U.K.
- AstraZeneca (Sweden) (SE)
- University of Wisconsin–Madison (US)
- Yale University (US)
- UNSW Sydney (AU)
- National University of Cordoba, Cordoba, Argentina
- Brigham and Women's Hospital (US)
- Universidad Nacional de Córdoba (AR)
- Copenhagen University Hospital (DK)
- Corresponding author
- McMurray, John J.V.
- ORCID
- Docherty, Kieran F.
- Bengtsson, Olof
- DeMets, David L.
- Inzucchi, Silvio E.
- Kosiborod, Mikhail N.
- Langkilde, Anna Maria
- Sabatine, Marc S.
- Sjöstrand, Mikaela
- Solomon, Scott D.
- McMurray, John J.V.
- Hershson, Alejandro
- Perna, Eduardo
- Cursack, Guillermo
- Nani, Sebastian
- Fairman, Enrique
- Pereira, Adamastor
- Neuenschwander, Fernando
- Reis, Gilmar
- Saraiva, José
- Hernandes, Mauro
- Manenti, Euler
- Rassi, Salvador
- Botushanov, Nikolay
- Pandey, Amritanshu
- Mehta, Shamir
- Poirier, Paul
- O’Meara, Eileen
- Howlett, Jonathan
- McKelvie, Robert
- Verma, Subodh
- Mansour, Samer
- Khaykin, Yaariv
- Lee, Rina
- Ge, Junbo
- Jiang, Hong
- Fu, Lu
- Li, Ying
- Zhao, Qiang
- Dong, Yugang
- Zhou, Yimeng
- Dong, Jianzeng
- Zhang, Xiaoli
- Gu, Ye
- Liu, Jinqiu
- Wu, Ling
- Tang, Qizhu
- Peng, Daoquan
- Dong, Wei
- Liang, Yingzi
- Wu, Chun
- Lin, Xuefeng
- Zhang, Xuelian
- Mayer, Otto
- Schou, Morten
- Egstrup, Kenneth
- Gislason, Gunnar
- Videbæk, Lars
- Böhm, Michael
- Kellerer, Monika
- Simonis, Gregor
- Petrie, Mark
- Gardner, Roy
- Clark, Andrew
- Japp, Alan
- Lang, Chim
- Leslie, Stephen
- Merkely, Béla
- Járai, Zoltán
- Chopra, V
- Naik, Ajay
- Karna, Sunil
- Kothiwale, Veerappa
- Menon, Jaideep
- Suzuki, Masahiro
- Nishino, Masami
- Kiyosue, Arihiro
- Suzuki, Shu
- Tanaka, Shinji
- Higashiue, Shinichi
- Iseki, Harukazu
- Sakuragi, Satoru
- Izumi, Chisato
- Oga, Takafumi
- Kimura, Akira
- Kakuta, Tsunekazu
- Matsuoka, Satoshi
- Hata, Yoshiki
- Fujimoto, Kazuteru
- Kadokami, Toshiaki
- Ueno, Hideki
- Shinozaki, Tsuyoshi
- Onishi, Yuko
- Inoue, Shujiro
- Momiyama, Yukihiko
- Komura, Yasuo
- Higuchi, Motoaki
- Fujii, Kenshi
- Harada, Ken
- Wada, Atsuyuki
- Kasai, Takatoshi
- Kuwahara, Koichiro
- Oishi, Shogo
- Okumura, Yasuo
- Tsukahara, Kengo
- Asakura, Masanori
- Bellersen, Louise
- Miękus, Paweł
- Prokopczuk, Janusz
- Galyavich, Albert
- Kopylov, Philipp
- Ezhov, Andrey
- Olexa, Peter
- Ljungman, Charlotta
- Hedman, Anders
- Lindmark, Krister
- Mooe, Thomas
- Lin, Lian-Yu
- Chang, Kuan-Cheng
- Shih, Jhih-Yuan
- Liu, Ping-Yen
- Lin, Tsung-Hsien
- Chang, Hung-Yu
- Huang, Jin-Long
- Wu, Chih-Cheng
- Arif, Ahmed
- Kanwar, Manreet
- Brown, Christopher
- Shah, Keyur
- Arouni, Amy
- Bertolet, Barry
- Cimato, Thomas
- Franchi, Francesco
- Hamroff, Glenn
- Kostis, John
- Lo, Eric
- Mody, Freny
- Hickey, Gavin
- Srivastava, Sunny
- Staniloae, Cezar
- Gupta, Dinesh
- Haddad, Tariq
- Lewis, Gregory
- Ogunniyi, Modele
- Emani, Sitaramesh
- Cheng, Richard
- Joseph, Susan
- Gupta, Deepak
- Izzo, Joseph
- Song, David
- Pham, Vinh
- Truong, Binh
- Nguyen, Tuan
- Ho, Dung
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2020-09-02
- Volume
- 43
- Issue
- 11
- Pages
- 2878-2881
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC7809714
- OpenAlex
- W3083297478
- Cited by
- 44
- References
- 16
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 4 · 2023: 5 · 2022: 5 · 2021: 25 · 2020: 2
- FWCI
- 6.98
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Diabetes Care (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, other-oa)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion, cc-by-sa)
- Funders
- AstraZeneca
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Keywords
- dapagliflozin, heart failure with reduced ejection fraction, type 2 diabetes, glucose-lowering therapy, SGLT2 inhibitors, DAPA-HF trial, treatment interaction, worsening heart failure, cardiovascular mortality, background therapy
- MeSH terms
- Sodium-Glucose Transporter 2 Inhibitors, Aged, Benzhydryl Compounds, Blood Glucose, Diabetes Mellitus, Type 2, Double-Blind Method, Drug Therapy, Combination, Female, Glucosides, Heart Failure, Hospitalization, Humans, Male, Metformin, Middle Aged, Prospective Studies, Stroke Volume, Proportional Hazards Models, Treatment Outcome, Kaplan-Meier Estimate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.